The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Network of the National Library of Medicine All of Us Program Center (U24) (Clinical Trial Optional) |
93.879 |
RFA-LM-21-002 |
| Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed) |
93.865 |
PAR-21-248 |
| Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-050 |
| Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans) |
93.121, 93.242, 93.273, 93.279, 93.307, 93.313, 93.399, 93.865, 93.866 |
PAR-21-280 |
| NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) |
93.242 |
PAR-21-239 |
| Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) |
93.279 |
RFA-DA-23-001 |
| Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) |
93.172 |
RFA-HG-21-002 |
| Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) |
93.121, 93.242, 93.273, 93.279, 93.307, 93.313, 93.399, 93.865, 93.866 |
PAR-21-281 |
| Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) |
93.172 |
RFA-HG-21-001 |
| PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) |
93.113, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.859, 93.865, 93.866 |
PA-21-261 |
| PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
93.068, 93.070, 93.073, 93.083, 93.084, 93.113, 93.136, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.286, 93.307, 93.316, 93.326, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.859, 93 |
PA-21-260 |
| PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
93.068, 93.070, 93.073, 93.083, 93.084, 93.103, 93.113, 93.121, 93.136, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.286, 93.307, 93.316, 93.326, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93 |
PA-21-259 |
| PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 |
PA-21-262 |
| Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed) |
93.279, 93.855 |
RFA-AI-21-041 |
| Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) |
93.242 |
PAR-21-264 |
| Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) |
93.242 |
PAR-21-263 |
| Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.393, 93.396, 93.847, 93.855 |
PAR-21-253 |
| HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) |
93.242, 93.279, 93.393, 93.394, 93.395, 93.396, 93.399, 93.846, 93.847, 93.866, 93.989 |
PAR-21-246 |
| Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed) |
93.393 |
RFA-CA-21-022 |
| Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers (UE5 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-22-020 |
| Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional) |
93.393 |
RFA-CA-21-021 |
| Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions Knowledgebase Management Center (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-014 |
| HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) |
93.213, 93.279, 93.846 |
RFA-DA-22-032 |
| Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-022 |
| HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) |
93.213, 93.279, 93.846 |
RFA-DA-22-031 |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) |
93.866 |
RFA-AG-22-027 |
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) |
93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93 |
PA-21-268 |
| Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed) |
93.121, 93.393 |
RFA-DE-22-003 |
| New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional) |
93.172, 93.286, 93.368 |
RFA-HG-21-025 |
| NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) |
93.867 |
PAR-21-204 |
| Exploratory Studies to Investigate the Mechanisms of Interrelationship between Sleep and Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required) |
93.279 |
RFA-DA-22-029 |
| Telehealth Strategies to Maximize HIV Care |
93.928 |
HRSA-22-030 |
| The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) |
93.113, 93.242, 93.279, 93.307, 93.313, 93.393, 93.396, 93.399, 93.866 |
PAR-21-275 |
| Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required) |
93.242 |
RFA-MH-21-240 |
| Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01 Clinical Trial Not Allowed) |
93.859 |
PAR-21-269 |
| CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed) |
93.113, 93.855, 93.867 |
RFA-ES-21-006 |
| NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) |
93.173 |
RFA-DC-22-001 |
| Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed) |
93.396 |
RFA-CA-21-027 |
| Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional) |
93.396 |
RFA-CA-21-026 |
| Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R21 Clinical Trial Not Allowed) |
93.121, 93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-DE-22-004 |
Search Results 2881-2920 of 15496
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 [Next] |
